PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+19.37%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$95.4M
AUM Growth
+$95.4M
(+5.9%)
Cap. Flow
-$3.4M
Cap. Flow
% of AUM
-3.56%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
118
New
12
Increased
18
Reduced
46
Closed
16
Top Buys
| 1 |
Vericel Corp
VCEL
|
$1.83M |
| 2 |
ATRS
Antares Pharma, Inc.
ATRS
|
$1.15M |
| 3 |
Bristol-Myers Squibb
BMY
|
$1.12M |
| 4 |
ATHX
Athersys, Inc. Common Stock
ATHX
|
$636K |
| 5 |
Veracyte
VCYT
|
$546K |
Top Sells
| 1 |
CryoPort
CYRX
|
$1.82M |
| 2 |
JetBlue
JBLU
|
$1.05M |
| 3 |
AtriCure
ATRC
|
$949K |
| 4 |
NCR Voyix
VYX
|
$854K |
| 5 |
SNAK
Inventure Foods, Inc.
SNAK
|
$705K |
Sector Composition
| 1 | Healthcare | 63.84% |
| 2 | Technology | 9.27% |
| 3 | Industrials | 8.69% |
| 4 | Communication Services | 3.79% |
| 5 | Financials | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$743M
| $10.4M | 10.94% | 539,598 -15,194 | -3% | -$294K |
|
2
Abbott
ABT
$231B
| $4.43M | 4.64% | 83,060 +350 | +0.4% | +$18.7K |
|
3
Rockwell Medical
RMTI
$58.9M
| $3.75M | 3.93% | 438,000 -2,134 | -0.5% | -$18.3K |
|
4
NeoGenomics
NEO
$1.13B
| $3.43M | 3.59% | 308,300 -500 | -0.2% | -$5.56K |
|
|
5
Vericel Corp
VCEL
$1.83B
| $3.38M | 3.54% | 562,600 +305,000 | +118% | +$1.83M |
|
6
LeMaitre Vascular
LMAT
$2.16B
| $2.88M | 3.02% | 77,075 -8,175 | -10% | -$306K |
|
|
VYNT
7
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
| $2.18M | 2.28% | 806,700 -21,666 | -3% | -$58.5K |
|
8
Idexx Laboratories
IDXX
$51.8B
| $2.18M | 2.28% | 14,000 | – | – |
|
9
Apyx Medical
APYX
$75.3M
| $2.11M | 2.21% | 623,685 +23,868 | +4% | +$80.7K |
|
|
10
AtriCure
ATRC
$1.84B
| $2.08M | 2.18% | 92,950 -42,418 | -31% | -$949K |
|
|
11
CryoPort
CYRX
$444M
| $2M | 2.09% | 202,990 -184,491 | -48% | -$1.82M |
|
|
CSII
12
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.87M | 1.96% | 66,550 -2,000 | -3% | -$56.3K |
|
13
Pfizer
PFE
$141B
| $1.85M | 1.94% | 51,934 -250 | -0.5% | -$8.93K |
|
14
AbbVie
ABBV
$372B
| $1.74M | 1.82% | 19,550 -100 | -0.5% | -$8.89K |
|
15
Integer Holdings
ITGR
$3.78B
| $1.72M | 1.8% | 33,550 -3,650 | -10% | -$187K |
|
16
Microsoft
MSFT
$3.77T
| $1.58M | 1.65% | 21,185 -400 | -2% | -$29.8K |
|
17
Eli Lilly
LLY
$657B
| $1.56M | 1.63% | 18,200 -250 | -1% | -$21.4K |
|
|
CGNT
18
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.44M | 1.5% | 560,881 -84,422 | -13% | -$216K |
|
19
Digital Turbine
APPS
$455M
| $1.38M | 1.44% | 911,080 +47,500 | +6% | +$71.7K |
|
20
IZEA Worldwide
IZEA
$64.3M
| $1.3M | 1.37% | 183,710 -625 | -0.3% | -$4.44K |
|
21
Aflac
AFL
$57.2B
| $1.26M | 1.32% | 15,450 +150 | +1% | +$12.2K |
|
|
ZIXI
22
DELISTED
Zix Corporation
ZIXI
| $1.24M | 1.3% | 253,579 -10,800 | -4% | -$52.8K |
|
|
ATRS
23
DELISTED
Antares Pharma, Inc.
ATRS
| $1.19M | 1.24% | 366,000 +356,000 | +3,560% | +$1.15M |
|
24
AT&T
T
$209B
| $1.18M | 1.24% | 30,162 -2,150 | -7% | -$84.2K |
|
25
CVS Health
CVS
$92.8B
| $1.16M | 1.21% | 14,200 +150 | +1% | +$12.2K |
|